Enanta Pharmaceuticals Inc
NASDAQ:ENTA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Enanta Pharmaceuticals Inc
NASDAQ:ENTA
|
US |
|
Imagin Medical Inc
F:DPD3
|
CA |
|
A
|
Argo Gold Inc
CNSX:ARQ
|
CA |
|
Brother Industries Ltd
TSE:6448
|
JP |
|
Canadian Gold Corp
XTSX:CGC
|
CA |
|
C
|
Compagnie de Saint Gobain SA
SIX:GOB
|
FR |
Shareholder Yield
Current shareholder yield for ENTA is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
ENTA Price
Enanta Pharmaceuticals Inc
| Average Annual Return | -32.79% |
| Standard Deviation of Annual Returns | 45.11% |
| Max Drawdown | -96% |
| Market Capitalization | 410m USD |
| Shares Outstanding | 29 080 000 |
| Percentage of Shares Shorted | 9.99% |
